On this page you'll find 2 example sentences with Bioventures. Discover how to use the word correctly in a sentence.
Bioventures in a sentence
Context around Bioventures
- Average sentence length in these examples: 30 words
- Position in the sentence: 0 start, 2 middle, 0 end
- Sentence types: 2 statements, 0 questions, 0 exclamations
Corpus analysis for Bioventures
- In this selection, "bioventures" usually appears in the middle of the sentence. The average example has 30 words, and this corpus slice is mostly made up of statements.
- Around the word, novartis, mpm and redmile stand out and add context to how "bioventures" is used.
- Recognizable usage signals include associates novartis bioventures redmile group and capital mpm bioventures ra capital. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "bioventures" sits close to words such as aabb, aabria and aacha, which helps place it inside the broader word index.
Example types with bioventures
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Investors in the firm have invested at least $29.4 million and include Atlas Venture, Forbion Capital, MPM Bioventures, RA Capital, Vida Ventures, Citadel Multi-Strategy and Wellington Biomedical. (29 words)
Investors in the firm have invested at least $145 million and include Bain Capital, Clarus Lifesciences, New Enterprise Associates, Novartis Bioventures (), Redmile Group, Muneer Satter trusts, Citadel and Zone II Healthcare. (31 words)
Investors in the firm have invested at least $145 million and include Bain Capital, Clarus Lifesciences, New Enterprise Associates, Novartis Bioventures (), Redmile Group, Muneer Satter trusts, Citadel and Zone II Healthcare. (31 words)
Investors in the firm have invested at least $29.4 million and include Atlas Venture, Forbion Capital, MPM Bioventures, RA Capital, Vida Ventures, Citadel Multi-Strategy and Wellington Biomedical. (29 words)
Example sentences (2)
Investors in the firm have invested at least $145 million and include Bain Capital, Clarus Lifesciences, New Enterprise Associates, Novartis Bioventures (), Redmile Group, Muneer Satter trusts, Citadel and Zone II Healthcare.
Investors in the firm have invested at least $29.4 million and include Atlas Venture, Forbion Capital, MPM Bioventures, RA Capital, Vida Ventures, Citadel Multi-Strategy and Wellington Biomedical.